Bar Harbor Wealth Management
IBB icon

Bar Harbor Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bar Harbor Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.63M Buy
17,222
+687
+4% +$138K 0.2% 98
2026
Q2 		$3.14M Buy
16,535
+71
+0.4% +$12.2K 0.17% 111
2026
Q1 		$2.78M Buy
16,464
+1,303
+9% +$223K 0.16% 115
2025
Q4 		$2.56M Buy
15,161
+268
+2% +$43.5K 0.15% 120
2025
Q3 		$2.15M Sell
14,893
-675
-4% -$92.1K 0.13% 125
2025
Q2 		$1.97M Buy
15,568
+276
+2% +$33.9K 0.13% 123
2025
Q1 		$1.96M Sell
15,292
-372
-2% -$50.4K 0.13% 121
2024
Q4 		$2.07M Buy
15,664
+838
+6% +$118K 0.14% 121
2024
Q3 		$2.16M Sell
14,826
-491
-3% -$71K 0.14% 126
2024
Q2 		$2.1M Sell
15,317
-808
-5% -$108K 0.14% 122
2024
Q1 		$2.21M Buy
16,125
+1,515
+10% +$207K 0.15% 128
2023
Q4 		$1.98M Buy
14,610
+153
+1% +$18.7K 0.15% 120
2023
Q3 		$1.77M Sell
14,457
-492
-3% -$62.6K 0.14% 121
2023
Q2 		$1.9M Sell
14,949
-3,440
-19% -$447K 0.15% 120
2023
Q1 		$2.38M Buy
+18,389
New +$2.41M 0.19% 108
2021
Q3 		– Sell
-1,719
Closed -$281K – 250
2021
Q2 		$281K Sell
1,719
-459
-21% -$70.7K 0.03% 205
2021
Q1 		$328K Sell
2,178
-43
-2% -$6.83K 0.03% 193
2020
Q4 		$336K Buy
2,221
+35
+2% +$5K 0.03% 190
2020
Q3 		$296K Hold
2,186
– – 0.03% 192
2020
Q2 		$299K Hold
2,186
– – 0.03% 188
2020
Q1 		$236K Sell
2,186
-773
-26% -$89K 0.03% 213
2019
Q4 		$357K Sell
2,959
-1,591
-35% -$178K 0.04% 230
2019
Q3 		$453K Sell
4,550
-84
-2% -$8.79K 0.05% 212
2019
Q2 		$506K Sell
4,634
-282
-6% -$30K 0.06% 201
2019
Q1 		$550K Sell
4,916
-295
-6% -$32.4K 0.07% 184
2018
Q4 		$502K Sell
5,211
-2,901
-36% -$308K 0.07% 188
2018
Q3 		$989K Buy
8,112
+848
+12% +$100K 0.11% 147
2018
Q2 		$798K Buy
7,264
+774
+12% +$82.8K 0.1% 161
2018
Q1 		$693K Buy
+6,490
New +$719K 0.08% 170

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.97% 1-Year Est. Return

Bar Harbor Wealth Management's IBB Position: Q3 2026 in Review

Bar Harbor Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 4.2% in Q3 2026, buying an estimated $138K and bringing the position to 17,222 shares worth $3.63M. The position accounts for 0.2% of the portfolio, ranked #98.

Bar Harbor Wealth Management first reported a position in IBB in Q1 2018 and has held it in 29 quarters since. 603 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Bar Harbor Wealth Management held 17,222 shares of iShares Biotechnology ETF worth $3.63M as of Q3 2026.
  • Bar Harbor Wealth Management bought 687 iShares Biotechnology ETF shares in Q3 2026, an estimated $138K.
  • iShares Biotechnology ETF made up 0.2% of Bar Harbor Wealth Management's portfolio in Q3 2026, its #98 holding.
  • Bar Harbor Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 29 quarters since.
  • 603 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.